300 related articles for article (PubMed ID: 35095864)
21. Protective effect of tertiary lymphoid structures against hepatocellular carcinoma: New findings from a genetic perspective.
Jia W; Yao Q; Wang Y; Mao Z; Zhang T; Li J; Nie Y; Lei X; Shi W; Song W
Front Immunol; 2022; 13():1007426. PubMed ID: 36189217
[TBL] [Abstract][Full Text] [Related]
22. Prognostication of inflammatory cells in liver transplantation: Is the waitlist neutrophil-to-lymphocyte ratio really predictive of tumor biology?
McVey JC; Sasaki K; Firl DJ; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Miller CC; Hashimoto K; Aucejo FN
Clin Transplant; 2019 Dec; 33(12):e13743. PubMed ID: 31655000
[TBL] [Abstract][Full Text] [Related]
23. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
Chen TM; Lin CC; Huang PT; Wen CF
J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of inflammation-based score in patients with hepatocellular carcinoma after liver transplantation.
Kong W; Qu E; Sheng N; Zhang J; Li X; Zheng J; Gao Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e282-e289. PubMed ID: 33405420
[TBL] [Abstract][Full Text] [Related]
26. PD-L1
Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
[No Abstract] [Full Text] [Related]
27. Using Pre-Treatment Neutrophil-to-Lymphocyte Ratio to Predict the Prognosis of Young Patients with Hepatocellular Carcinoma Implemented Minimally Invasive Treatment.
Sun S; Wang X; Chen J
J Adolesc Young Adult Oncol; 2020 Feb; 9(1):85-89. PubMed ID: 31621472
[No Abstract] [Full Text] [Related]
28. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
29. Preoperative neutrophil-to-lymphocyte ratio predicts recurrence of patients with single-nodule small hepatocellular carcinoma following curative resection: a retrospective report.
Liao R; Tang ZW; Li DW; Luo SQ; Huang P; Du CY
World J Surg Oncol; 2015 Sep; 13():265. PubMed ID: 26328917
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
31. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy.
Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Liang LJ; Peng BG
Med Oncol; 2013 Dec; 30(4):721. PubMed ID: 24026659
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of the neutrophil-to-lymphocyte ratio for hepatocellular carcinoma patients with portal/hepatic vein tumor thrombosis.
Li SH; Wang QX; Yang ZY; Jiang W; Li C; Sun P; Wei W; Shi M; Guo RP
World J Gastroenterol; 2017 May; 23(17):3122-3132. PubMed ID: 28533669
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram.
Wang S; Deng Y; Yu X; Zhang XW; Huo CL; Sun ZG; Chang H
Sci Rep; 2021 Jul; 11(1):13814. PubMed ID: 34226605
[TBL] [Abstract][Full Text] [Related]
35. Validation of inflammation-based prognostic models in patients with hepatitis B-associated hepatocellular carcinoma: a retrospective observational study.
Pang Q; Zhou L; Qu K; Cui RX; Jin H; Liu HC
Eur J Gastroenterol Hepatol; 2018 Jan; 30(1):60-70. PubMed ID: 29189392
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of the preoperative neutrophil-to-lymphocyte ratio for the development of hepatocellular carcinoma in HBV-associated cirrhotic patients after splenectomy.
Du Z; Dong J; Bi J; Bai R; Zhang J; Wu Z; Lv Y; Zhang X; Wu R
PLoS One; 2018; 13(4):e0195336. PubMed ID: 29621282
[TBL] [Abstract][Full Text] [Related]
37. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
Chiu TJ; Chen YJ; Kuo FY; Chen YY
PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
[TBL] [Abstract][Full Text] [Related]
38. Combined inflammatory parameters and tertiary lymphoid structure predict prognosis in patients with resectable non-small cell lung cancer treated with neoadjuvant chemoimmunotherapy.
Xu F; Zhu H; Dong Y; Li L; Liu N; Yuan S
Front Immunol; 2023; 14():1244256. PubMed ID: 38155965
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy.
Li JX; He ML; Qiu MQ; Yan LY; Long MY; Zhong JH; Zhang RJ; Liang CF; Pang YD; He JK; Chen QQ; Weng JX; Liang SX; Xiang BD
BMC Gastroenterol; 2022 Dec; 22(1):510. PubMed ID: 36494634
[TBL] [Abstract][Full Text] [Related]
40. The blood neutrophil-to-lymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib.
Zheng YB; Zhao W; Liu B; Lu LG; He X; Huang JW; Li Y; Hu BS
Asian Pac J Cancer Prev; 2013; 14(9):5527-31. PubMed ID: 24175853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
